BP Directors, LP
CIK 0001813311 Name as filed on the most recent filing
Filed as BP Directors, LP (12)
71 transaction lines · from 12 filings · filed 2022-09-07 to 2025-06-30 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2025-06-27 |
Actuate Therapeutics, Inc. ACTU |
P, Open-market purchase | 71,428 acquired | 7.00 | 499,996.00 | Form 4, filing 0001104659-25-063993 | |
| 2025-06-13 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 14,218 disposed | 3.09 | 43,933.62 | Form 4, filing 0001104659-25-059526 | |
| 2025-06-13 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 12,319 disposed | 3.09 | 38,065.71 | Form 4, filing 0001104659-25-059526 | |
| 2025-06-13 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 7,206 disposed | 3.09 | 22,266.54 | Form 4, filing 0001104659-25-059526 | |
| 2025-06-13 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 4,354 disposed | 3.09 | 13,453.86 | Form 4, filing 0001104659-25-059526 | |
| 2025-06-13 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 1,903 disposed | 3.09 | 5,880.27 | Form 4, filing 0001104659-25-059526 | |
| 2025-06-12 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 21,557 disposed | 3.38 | 72,862.66 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-12 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 18,678 disposed | 3.38 | 63,131.64 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-12 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 10,925 disposed | 3.38 | 36,926.50 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-12 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 6,601 disposed | 3.38 | 22,311.38 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-12 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 2,886 disposed | 3.38 | 9,754.68 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-11 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 338 disposed | 3.40 | 1,149.20 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-11 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 293 disposed | 3.40 | 996.20 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-11 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 171 disposed | 3.40 | 581.40 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-11 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 103 disposed | 3.40 | 350.20 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-11 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 45 disposed | 3.40 | 153.00 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-10 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 5 disposed | 3.40 | 17.00 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-10 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 5 disposed | 3.40 | 17.00 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-10 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 3 disposed | 3.40 | 10.20 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-10 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 2 disposed | 3.40 | 6.80 | Form 4, filing 0001104659-25-059091 | |
| 2025-06-10 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 1 disposed | 3.40 | 3.40 | Form 4, filing 0001104659-25-059091 | |
| 2025-05-29 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 7,180 disposed | 3.03 | 21,755.40 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-29 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 6,221 disposed | 3.03 | 18,849.63 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-29 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 3,639 disposed | 3.03 | 11,026.17 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-29 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 2,199 disposed | 3.03 | 6,662.97 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-29 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 961 disposed | 3.03 | 2,911.83 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-28 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 5,332 disposed | 2.87 | 15,302.84 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-28 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 4,620 disposed | 2.87 | 13,259.40 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-28 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 2,702 disposed | 2.87 | 7,754.74 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-28 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 1,632 disposed | 2.87 | 4,683.84 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-28 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 714 disposed | 2.87 | 2,049.18 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-27 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 7,478 disposed | 3.05 | 22,807.90 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-27 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 6,479 disposed | 3.05 | 19,760.95 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-27 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 3,790 disposed | 3.05 | 11,559.50 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-27 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 2,290 disposed | 3.05 | 6,984.50 | Form 4, filing 0001104659-25-054421 | |
| 2025-05-27 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 1,000 disposed | 3.05 | 3,050.00 | Form 4, filing 0001104659-25-054421 | |
| 2024-08-14 |
Actuate Therapeutics, Inc. ACTU |
S, Open-market sale | 17,361 disposed | 8.00 | 138,888.00 | Form 4, filing 0001104659-24-091372 | |
| 2024-08-14 |
Actuate Therapeutics, Inc. ACTU |
S, Open-market sale | 2,324 disposed | 8.00 | 18,592.00 | Form 4, filing 0001104659-24-091372 | |
| 2024-08-14 |
Actuate Therapeutics, Inc. ACTU |
S, Open-market sale | 5,314 disposed | 8.00 | 42,512.00 | Form 4, filing 0001104659-24-091372 | |
| 2024-08-14 |
Actuate Therapeutics, Inc. ACTU |
S, Open-market sale | 17,361 disposed | 9.00 | 156,249.00 | Form 4, filing 0001104659-24-089825 | |
| 2024-08-14 |
Actuate Therapeutics, Inc. ACTU |
S, Open-market sale | 5,314 disposed | 9.00 | 47,826.00 | Form 4, filing 0001104659-24-089825 | |
| 2024-08-14 |
Actuate Therapeutics, Inc. ACTU |
S, Open-market sale | 2,324 disposed | 9.00 | 20,916.00 | Form 4, filing 0001104659-24-089825 | |
| 2024-08-14 |
Actuate Therapeutics, Inc. ACTU |
P, Open-market purchase | 375,000 acquired | 8.00 | 3,000,000.00 | Form 4, filing 0001104659-24-089825 | |
| 2024-08-14 |
Actuate Therapeutics, Inc. ACTU |
P, Open-market purchase | 125,000 acquired | 8.00 | 1,000,000.00 | Form 4, filing 0001104659-24-089825 | |
| 2024-05-24 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 13,888 disposed | 6.33 | 87,911.04 | Form 4, filing 0001104659-24-065619 | |
| 2024-05-24 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 4,253 disposed | 6.33 | 26,921.49 | Form 4, filing 0001104659-24-065619 | |
| 2024-05-24 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 1,859 disposed | 6.33 | 11,767.47 | Form 4, filing 0001104659-24-065619 | |
| 2024-05-23 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 6,944 disposed | 6.25 | 43,400.00 | Form 4, filing 0001104659-24-065619 | |
| 2024-05-23 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 2,126 disposed | 6.25 | 13,287.50 | Form 4, filing 0001104659-24-065619 | |
| 2024-05-23 |
Lantern Pharma Inc. LTRN |
S, Open-market sale | 930 disposed | 6.25 | 5,812.50 | Form 4, filing 0001104659-24-065619 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. BP Directors, LP, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001813311
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6